N. Takahashi

Statistics

Publications

Citations

235

H-Index

Active since

1977

Affiliations

Clinical Research Institute(Current)

Canadian VIGOUR Centre

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Alberta

Bayer (Germany)

N. Takahashi is an author at Clinical Research Institute specializing in cardiology, cardiovascular pharmacotherapy, and heart failure pharmacotherapy.

Publications per year

1977–2025

Publications

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Biology of Rice.

S. Tsunodo, N. Takahashi · 1984 · 71 citations

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Interaction of Sesamin and Eicosapentaenoic Acid against<i>Δ</i>5 Desaturation and n-6/ n-3 Ratio of Essential Fatty Acids in Rat

Rumi Umeda‐Sawada, N. Takahashi, Osamu Igarashi · Bioscience Biotechnology and Biochemistry · 1995 · 20 citations

Life Sciences, Biochemistry, Nutritional Sciences +17

Cyclo-<scp>L</scp>-leucyl-<scp>L</scp>-histidyl monohydrate

Isao Tanaka, Takehiko Iwata, N. Takahashi et al. · Acta Crystallographica Section B · 1977 · 17 citations

1–5 of 6